Background. The first European rotavirus surveillance network, EuroRotaNet, comprising 16 laboratories in 15 European countries, has been established.
The specific aims of EuroRotaNet are the following: (1) to develop methods and algorithms for effective rotavirus typing (G and P) and characterization (including VP6 and NSP4 genotypes); (2) to monitor the effectiveness of current genotyping methods and to respond to changes associated with genetic drift and shift; (3) to describe in detail the molecular epidemiology of rotavirus infections in Europe during consecutive rotavirus seasons, through genotyping of rotavirus-positive samples collected throughout each country; (4) to monitor the emergence and spread of novel rotavirus strains throughout Europe; and (5) to develop the infrastructure that may inform future surveillance activities and nested studies for evaluation of (a) the effectiveness of rotavirus vaccines in the general population, through monitoring the reduction in disease associated with common rotaviruses, and (b) the possible vaccine-induced emergence of antibody-escape mutants, genotypes other than those included in the vaccine, and/or reassortants of vaccine and naturally circulating wild-type strains. This article reports the data collected through EuroRotaNet to date.
MATERIALS AND METHODS
Study area. Currently, the EuroRotaNet database holds data from 19 European countries. In 2007, the study area consisted initially of 11 European countries, including Denmark, Finland, France, Germany, Hungary, Italy, The Netherlands, Slovenia, Spain, Sweden, and the United Kingdom. An additional 3 European countries, Belgium, Bulgaria, and Lithuania, joined in 2008, and Greece and Romania joined in January 2009. In addition, data from countries that are not formal members of EuroRotaNet, including Azerbaijan, Georgia, Portugal, Tajikistan, and Ukraine, were uploaded to the database. The database contains data from hospitalized cases and from cases in the community, collected from rural and urban populations. The minimum number of samples that each country needs to test to be able to detect strains circulating with an incidence of 1% has been calculated from data obtained in previous studies [1, 2] and has been set as a target for rotavirus characterization in each country.
Sample collection. Fecal samples submitted for investigation of gastroenteritis that tested positive for group A rotavirus antigen were collected for genotyping. Hospitals, pediatricians, and general medical practitioners in the community who were willing to participate in the surveillance over several years were identified in each of the participating countries to allow valid comparisons to be made between each rotavirus season and within each member country. The denominator of the number of children aged !5 years in each catchment area is provided whenever possible. Although rotavirus is investigated as a cause of gastroenteritis mainly in children aged !5 years, no age limit has been set. This is important because the emergence of novel strains is often associated with infection and disease in older individuals [1] .
Epidemiological data. Data including age, sex, geographical location, setting (hospital or community), dates of onset and sample collection, and clinical symptoms (diarrhea and/or vomiting or other symptoms) were collected and linked to the genotyping data.
Genotyping and strain characterization. Rotavirus strains were genotyped to identify their G and P types [1, 2] . Rotavirus VP6 subgroups and NSP4 genotypes were determined for uncommon or novel strains identified through G and P typing, to identify possible zoonotic transmission [3] . The testing algorithm and genotyping methods are available on the EuroRotaNet Web site (http://www.eurorota.net/).
The majority of EuroRotaNet participants have ample experience with rotavirus characterization, and genotyping is performed by a designated laboratory in each country (there are 2 designated laboratories in Spain). Quality assurance was determined by circulation of blinded panels of well-characterized rotavirus strains to all participants on a yearly basis to ensure comparability of data.
Data sharing and analysis. A Web-accessible database (http://www.eurorota.net/) was developed by the Health Protection Agency to provide a central portal for dissemination of network information and for submission and interrogation of disparate surveillance data. The public interface provides unrestricted access to information on EuroRotaNet, as well as on rotavirus, rotavirus characterization methods, and relevant publications and links to other related sites of interest. Participants in the network have password-protected access to rotavirus strain types, epidemiological data, analysis tools, and a bulletin board to facilitate communication among network members. Analytical tools have been developed to query the online database, which allows real-time analysis of the distribution of rotavirus genotypes temporally, geographically (by country), or by age, sex, or setting (hospital or community). The data can be analyzed and compared according to calendar year or rotavirus season (September-August). Other tools, such as geographical analysis, are currently being developed.
RESULTS
The database contains 14,315 entries from a total of 19 European countries, and more than one-half ( Table 1 for a detailed breakdown of the countries included each season). Data from 2007-2008 were preliminary at the time that the manuscript of this Differences in the month in which rotavirus infections peaked were observed across the EuroRotaNet countries. The earliest peaks were detected in Spain in January, and in Italy in March. In France and the United Kingdom, the incidence of infection peaked in April, and in the Scandinavian countries and in Hungary and Slovenia, the peak of infection was in May (Table 2) .
Genotype distribution. The most common rotavirus genotype detected during the 3 rotavirus seasons from 2005 through 2008 was G1P [8] (Table 2) ). The incidence of infection P ! .001 with G3P [8] strains remained stable during the 3 consecutive seasons, whereas significant differences were observed from season to season in the incidence of infection with G4P [8] strains ( ). G12P [8] strains were detected in several European P ! .001 countries, with a relatively low incidence of infection with these strains during the 2005-2006 season, and the incidence remained similar through 2007-2008 ( Table 2) .
The relative incidence of infection with the various genotypes differed among the participating countries and among seasons (Table 3 ). G1P [8] was the most common genotype in Denmark, France, the United Kingdom, and Slovenia during each of the 3 rotavirus seasons, although the relative incidence of infection with G1P [8] strains varied from season to season (Table 3 ). In addition, the incidence of infection with G2P [4] No significant differences were seen in the incidence of rotavirus infections reported in male and female individuals (55% and 45% of 5805 individuals, respectively), and no differences were observed in the distribution of genotypes between the sexes (data not shown).
Of 7081 rotavirus infections in 2005-2008 for which the setting was recorded, 65% were hospitalized cases and 35% were community cases. The percentages of the different genotypes detected in hospital or community cases followed the same distribution, with the exception of G2P [4] strains, which were found significantly more often in hospitalized cases ( ; data not shown). P ! .001
DISCUSSION
EuroRotaNet provides consistent and comparable data on rotavirus strain diversity across Europe through national networks for sampling and the use of standardized methods for strain characterization. Rotavirus infections are nonnotifiable, and this network has no influence on the national surveillance of rotavirus infections in the different European countries. However, the data obtained in this study should be representative of the strains circulating in each of the countries and provide a more robust comparison among countries and seasons than do data from small, isolated, and country-centric studies published previously.
Analysis of the EuroRotaNet database revealed that, for the 3 rotavirus seasons from 2005 through 2008, G1P [8] remained the most prevalent genotype in Europe as a whole, but the incidence of infection with G1P [8] strains remained !50%. All 3 seasons were characterized by a significant diversity of cocirculating strains. Recently, an increase in the incidence of infection with G2P [4] rotavirus strains has been reported in Brazil, where the monovalent G1P [8] rotavirus vaccine is currently being used [4, 5] . This finding raises questions about the ability of this vaccine to confer cross-protection against G2P [4] rotavirus disease and the possibility that the increased incidence of infection with rotavirus of this genotype is being driven by the introduction of the vaccine. However, data from the EuroRotaNet network indicated a significant increase in the incidence of infection with G2P [4] [1, 2] . Interestingly, G2P [4] rotavirus infections in Europe were significantly associated with hospital cases and are possibly associated with more-severe disease. The reemergence of G2P [4] strains has previously been associated with mutations within antigenic sites on the VP7 gene leading to the emergence of antibody escape mutants [6] [7] [8] , and this may also explain the association of G2P [4] strains with moresevere disease. Significant differences were also observed in the relative incidences of infection with the various rotavirus genotypes among countries (Table 3 ). The incidence of infection with strains of zoonotic origin fluctuated between 0% and 7.8% among these 5 countries. Remarkably, Denmark reported the highest incidence of infection with such strains in 2005-2006, but none were reported in the subsequent seasons. Further analysis of these data should clarify whether the high incidence reported in 2005-2006 was limited to a particular location and/ or represented an outbreak. Interestingly, 1.34% of all strains in the database from 2005 through 2008 had unusual G and/ or P types, suggesting either direct zoonotic transmission or reassortment between zoonotic and human strains, as previously documented [1, 3, [9] [10] [11] [12] [13] [14] [15] .
If extrapolated across the 14 European countries, with an estimated 3,579,070 cases of rotavirus infection, this would account for a mean of 47,959 cases of infection with rotavirus strains of possible zoonotic origin each year. Among these, it is of note that G9P [6] strains have reemerged in Hungary. G9 strains first emerged in Europe in 1995 as G9P [6] strains and were likely introduced through zoonosis [1] . Subsequently, the G9P [8] genotype originated through reassortment with human strains and spread throughout Europe and the rest of the world to become a common human strain, displacing G9P [6] strains [1] . This finding may suggest zoonotic reintroduction of G9P [6] into Europe, and further investigation suggested that these strains were imported from India [16] . G12 in combination with P [6] , P [8] , or P [9] has been detected among strains in Europe, although the incidence of infection with these strains remained relatively low.
The data being gathered through EuroRotaNet will provide valuable background information on the rotavirus strain diversity in Europe before the introduction of rotavirus vaccines, and the network will provide a robust method for surveillance during vaccination implementation. Furthermore, because rotavirus vaccination is not being introduced equally across Europe, comparisons of genotype distributions between neighboring countries with and without universal rotavirus vaccination programs will be possible. Although still preliminary, the data collected through EuroRotaNet suggest a southto-north and west-to-east pattern of rotavirus spread in Europe. Continued monitoring in consecutive seasons though this net- work will provide evidence as to whether this is a true and repetitive phenomenon.
